We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Allogeneic Stem Cell Transplantation, Severe Homzygous 0/+Thalassemia or Sever Variants of Beta 0/+ Thalassemia, THALLO (THALLO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00578292
Recruitment Status : Terminated (Over the course of this study stem cell transplant was determined to be standard of care for this disease and as such the study is no longer relevant.)
First Posted : December 21, 2007
Last Update Posted : July 22, 2016
Sponsor:
Collaborator:
Texas Children's Hospital
Information provided by (Responsible Party):
Kathryn Leung, Baylor College of Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : May 2016
  Study Completion Date : May 2016